Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 312 followers
Latest posts
Last updated about 7 hours ago
Months after layoffs, AbbVie-partnered protein degrader specialist Plexium raises $60M
about 7 hours ago
Plexium has raised $60.1 million, providing an infusion of cash to the...
FDA considers non-invasive liver endpoint for clinical trials, sending MASH biotechs’ shares up
about 9 hours ago
The FDA has begun considering a non-invasive liver measurement as a surrogate...
FDA flags issues in review of Telix’s PET diagnostic agent for kidney cancer
about 9 hours ago
The FDA has asked Telix for more information about the manufacturing of...
Flagship taps IQVIA as biotech support for company fleet
about 9 hours ago
Flagship Pioneering is boosting the clinical research capabilities of its biotech fleet...
Novo Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal
about 13 hours ago
As obesity pioneer Novo Nordisk loses ground in the race for next-generation...
Prothena’s Alzheimer trial hit by ARIA showstopper, resulting in ‘non-competitive’ profile
about 13 hours ago
A phase 1 study has linked Prothena’s anti-amyloid beta antibody to a...
Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing
1 day ago
Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga in a...
New foundation from Microsoft co-founder reveals inaugural research grants, pledges $500M funding
1 day ago
A new foundation from the estate of late Microsoft co-founder Paul Allen...
3D-printed orthopedic implant maker restor3d raises $104M
1 day ago
That includes $65 million in a new equity investment from Partners Group...
Amylyx axes rare disease program after Relyvrio fails to beat placebo
1 day ago
Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on primary or...
MA's biopharma hotbed shed R&D, manufacturing workers in '24, as new threats now come to the fore
1 day ago
A new report from MassBio suggests the state isn’t immune to the...
Wugen woos VCs, landing $115M to bring fratricide-resistant CAR-T cell therapy to market
1 day ago
Wugen has raised $115 million, tapping a Fidelity-led syndicate to fund its...